pillbase.ru

ReHydration

Active substance: ADENOSINE CYCLIC PHOSPHATE, ARABICA COFFEE BEAN, SUS SCROFA ADRENAL GLAND, BOS TAURUS HYPOTHALAMUS, DIBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE, SARSAPARILLA, SILICON DIOXIDE, TARAXACUM OFFICINALE ROOT, THYROID, UNSPECIFIED

LIQUID · ADENOSINE CYCLIC PHOSPHATE 12 [hp_X]/118.2mL, ARABICA COFFEE BEAN 9 [hp_X]/118.2mL, SUS SCROFA ADRENAL GLAND 9 [hp_X]/118.2mL, BOS TAURUS HYPOTHALAMUS 12 [hp_X]/118.2mL, DIBASIC POTASSIUM PHOSPHATE 6 [hp_X]/118.2mL, SODIUM CHLORIDE 8 [hp_X]/118.2mL, SARSAPARILLA 4 [hp_X]/118.2mL, SILICON DIOXIDE 12 [hp_X]/118.2mL, TARAXACUM OFFICINALE ROOT 4 [hp_X]/118.2mL, THYROID, UNSPECIFIED 12 [hp_X]/118.2mL

United StatesActive

Marketing holder: Energetix Corporation

Verified 2026-10-09 · openFDA NDC

Composition
Registration
Registration number
64578-0175
Registration status
Active
Dispensing
Over the counter
Route
ORAL
Sources
  • product · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.2 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.3 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.4 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.5 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.6 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.7 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.8 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source
  • ingredients.9 · openFDA NDC · 64578-0175 · Verified 2026-10-09 · open in source